Zobrazeno 1 - 10
of 14
pro vyhledávání: '"BERTI NELWAN"'
Autor:
Muhammad Irfan Kamaruddin, Andi Alfian Zainuddin, Berti Nelwan, Sri Asriyani, Firdaus Hamid, Tenri Esa, Irawan Yusuf
Publikováno v:
The Asia Pacific Scholar, Vol 9, Iss 2, Pp 39-50 (2024)
Introduction: A good learning environment (LE) will affect the quality and standard of the learning process, student performance, and the outcome of the curriculum as well as predictor of the quality of health services. Our study aims to assess resid
Externí odkaz:
https://doaj.org/article/57eccdc04e48482e9627114925d329cd
Autor:
KHAERIAH AMRU, FIRDAUS HAMID, ICHLAS AFANDI, ASTY AMALIA, BUDU MANNYU, BERTI NELWAN, NASRUDDIN MAPPAWARE
Publikováno v:
Journal of Advances in Medical Education and Professionalism, Vol 11, Iss 4, Pp 222-229 (2023)
Introduction: 1000 First Days of Life (1000FDL) training program is carried out for 2 years from the 3rd to 6th semester;in this program, students are asked to accompany pregnant women until their children are 2 years old. This study aimed to analyse
Externí odkaz:
https://doaj.org/article/c265ea878af5404b92b96b98666009ad
Autor:
Yolanda Manule, Upik Miskad, Rina Masadah, Berti Nelwan, Muhammad Husni Cangara, Mardiati Mardiati
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 24:1413-1417
Autor:
Berti Nelwan, Djumadi Ahmad, Upik A. Miskad, Rina Masadah, Andi Alfian Zainuddin, Halidah Rahawarin, Prihantono Prihantono, Rizki A. Rifai, Husni Cangara
Publikováno v:
Breast disease. 40(S1)
BACKGROUND: The immune system is known to play an important role in tumor cell eradication. Although cancer cells were able to escape from the immune system, many studies showed mononuclear inflammatory cell infiltrates known as tumor-infiltrating ly
Autor:
Indra Indra, Muhammad Faruk, Salman Ardy Syamsu, Elridho Sampepajung, Septiman Rahman, Prihantono Prihantono, Agung Sindu Pranoto, Haryasena Haryasena, Daniel Sampepajung, Berti Nelwan
Publikováno v:
Breast disease. 40(S1)
INTRODUCTION: Programmed death ligand 1 (PD-L1) plays a role in tumor escape and progression by inactivating T lymphocytes. The aim of the study reported here was to determine the relationship between the expression of PD-L1 and histopathological gra
Publikováno v:
Breast disease. 40(S1)
BACKGROUND: Approximately 70–80% of breast cancer express ER-alpha and hormonal therapies, given significant improvements in patient survival. About 50% of ER-positive breast cancer patients with advanced disease insensitive to tamoxifen treatment
Publikováno v:
Breast disease. 40(S1)
OBJECTIVES: This study aims to evaluate and compare four breast cancer subtypes defined by immunohistochemistry expression of ER, PR, and HER-2 in correlation with Ki-67 and GATA-3 expression. METHODS: Slides from 89 paraffin blocks of invasive breas
Autor:
Syarifuddin Wahid, Andi Alfian Zainuddin, Berti Nelwan, Mahmud Ghaznawie, Rina Masadah, Dzul Ikram
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 22(11)
Objective To analyze the role of cancer stem cells (CSC) in ovarian carcinogenesis through the identification of CD133 expression in the normal ovary (NO), serous cystadenoma (SC), borderline serous tumour (BST), low-grade serous carcinoma (LGSC), an
Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in colorectal adenocarcinoma
Autor:
Muhammad Husni Cangara, Nursakti Hamzah, Syarifuddin Wahid, Upik A. Miskad, Rina Masadah, Berti Nelwan
Publikováno v:
Minerva Medica. 111
BACKGROUND Programmed death-ligand 1 (PD-L1) expression and tumor-infiltrating lymphocytes (TILs) are considered have a prognostic value in several malignancies. This study investigated the correlation between PD-L1 expression of tumor cells with the
Autor:
Andi Asadul Islam, Christian Binekada, Prihantono Prihantono, Daniel Sampepajung, Berti Nelwan, Mochammad Hatta, Haryasena Haryasena, Andi Nilawati Usman
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2017 (2017)
Journal of Oncology, Vol 2017 (2017)
Background. Chemotherapy has become a standard of treatment in managing breast cancer. To achieve proper treatment for the right patients, the predictive marker is needed. Ki-67 is a biomarker of proliferation for solid tumor. Studies mentioned assoc